Britain began vaccinating its population with Oxford University and AstraZeneca’s Covid-19 shot on Monday in a world first, racing to give protection to the elderly and vulnerable as a new surge of cases threatened to overwhelm hospitals.
Britain touted a scientific “triumph” as dialysis patient Brian Pinker, 82, became the first person to get the Oxford/AstraZeneca shot outside of a trial. As major powers eye the benefits of being first out of the pandemic, Britain is rushing to vaccinate its population faster than the United States and the rest of Europe, although Russia and China have been inoculating their citizens for months.
Just under a month since Britain became the first country to roll out the vaccine developed by Pfizer and Germany’s BioNTech, Pinker, who has kidney disease, received the Oxford/AstraZeneca shot. “I am so pleased to be getting the Covid vaccine today and really proud that it is one that was invented in Oxford,” Pinker, a retired maintenance manager, said just a few hundred metres from where the vaccine was developed.
Meanwhile, Scientists are not fully confident that vaccines will work on a new variant of the coronavirus found in South Africa, ITV's political editor said on Monday, citing an unidentified scientific adviser to the British government. British Health Secretary Matt Hancock said earlier on Monday that he was incredibly worried about the new variant.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU